Bigtimer, here's the PR on the Basket cancer trial
Post# of 148337
https://www.cytodyn.com/newsroom/press-releas...cer-tumors
You might ask the Research Coordinator, Emily Jennings of Quest Clinical Research, directly. emily@questclinical.com
The initial screening must take place in San Francisco -- just so you know.
They need 5 unstained slides and a pathology report from either her primary tumor biopsy or a metastases. Once they receive the slides and pathology report, they send them to the lab to be tested for CCR5 receptors. This tells them whether the patient will benefit.
Lots of luck! Hope it works out for you.